Sunday, September 13, 2026

AI systems now execute cryptocurrency payments, influence US military strikes on Iran

MoonPay launched autonomous payment agents on February 24, 2026, while Claude AI helps prioritize US strike targets in Iran. The shift from question-answering chatbots to action-executing agents is accelerating across financial services, military operations, and healthcare in Q1 2026.

AI systems now execute cryptocurrency payments, influence US military strikes on Iran
Image generated by AI for illustrative purposes. Not actual footage or photography from the reported events.

MoonPay launched autonomous payment agents on February 24, 2026, enabling AI systems to execute cryptocurrency transactions without human approval. Claude AI is simultaneously helping US forces identify and prioritize strike targets in Iran, MIT Technology Review reported.

The deployment marks a global transition from chatbots that answer questions to agents that take action. "Companies have AI that can answer questions, but not AI that can act," said MoonPay's Murali Swaminathan.

Three agent categories are emerging across international markets: financial agents executing transactions, tactical agents recommending military actions, and workflow agents automating professional services. Rad AI's healthcare system makes scheduling decisions for radiologists without human intervention.

Enterprise adoption requires new infrastructure unavailable in most markets. AI agents need API integrations, permission frameworks limiting action scope, and audit trails tracking autonomous decisions. These differ from text-generating chatbots deployed globally since 2022.

The shift changes development priorities worldwide. Traditional large language models optimize for accuracy and knowledge retrieval. Autonomous agents require decision-making frameworks and safety constraints preventing unintended consequences.

Liability questions remain unresolved across jurisdictions. When AI agents execute payments or influence military strikes, accountability frameworks must determine responsibility for autonomous decisions. Current regulations in the US, EU, and Asia treat AI as advisory tools, not decision-making entities.

Investment is flowing toward agentic platforms. MoonPay Agents targets developers building AI applications interacting with financial systems, creating a category beyond conversational AI tools dominating markets since ChatGPT's 2022 launch.

Q1-Q2 2026 will test global enterprise appetite for autonomous agents versus traditional chatbots. Early adoption in US military operations and international payment systems suggests high-stakes domains are moving fastest, despite greater risks and regulatory uncertainty across borders.


Sources:
1 Yahoo Finance, "Commotion Launches Enterprise AI Operating System Powered by NVIDIA Nemotron™ Open Models to Scale P" (February 23, 2026)
2 Yahoo Finance, "This Nuclear Energy Trend Could Be Bigger Than Investors Think in 2026" (March 21, 2026)
3 Nasdaq, "1 Artificial Intelligence (AI) Stock That Could Be Worth a Fortune by 2030" (March 21, 2026)
4 Yahoo Finance, "History says these 2 overlooked asset classes are the only real shield against 1970s-style stagflati" (March 21, 2026)
5 Yahoo Finance, "Nadella paid $650M to recruit his AI chief. After 2 years he's quietly pushing him aside — these bru" (March 21, 2026)

In this story · Knowledge Files

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
AI Capital Keeps Flowing as Enterprise Adoption and Government Contracts Validate the Bet
A late-August surge of nine-figure funding rounds (Socure, Stability AI, Generalist AI, Gatik, Regent Craft, Emerald AI, Owner) shows venture capital still pouring into AI infrastructure, identity/fintech, and autonomy, even as public-market sentiment stays jumpy — Palantir's stock fell 6% the same week it landed the Army's TITAN contract. UiPath's raised guidance and strong Q2 results, alongside efficiency breakthroughs like Multiverse Computing's model compression, point to real enterprise monetization catching up to the funding hype.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
JPMorgan Chase & Co.
Both facts record the same attribute (net_income) for JPMorgan Chase & Co. in the identical fiscal period (Q1 2026) and observation date (2026-03-31), but report values that differ by approximately 1 billion times: $16,494,000,000 vs $16.49. These cannot both be true simultaneously. The discrepancy suggests either a unit mismatch (e.g., one is total net income, the other earnings per share mislabeled as net_income), a decimal point error, or data entry corruption. For the same entity, attribute, and time period, only one value can be correct.
We flag conflicts openly ›
Recently verified
Checked against the original source
4,981
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,981 facts checked against source5,280 source documents archived
Query this data → isubstrate.com